Humacyte presents vessel data in five presentations at VEITHsymposium
HUMA•Humacyte will feature its acellular tissue engineered vessel in five presentations at VEITHsymposium, Nov. 17-21, 2026, in New York. Topics include interim Phase 3 dialysis results in women, integrated outcomes from three Phase 3 trials and Symvess clinical results in vascular trauma settings.
1. Presentation schedule
Humacyte will feature its acellular tissue engineered vessel in five presentations at VEITHsymposium in New York from Nov. 17-21, 2026. Four presentations on Nov. 18 include interim Phase 3 dialysis results in women and integrated outcomes from three Phase 3 trials.
2. Symvess results
A Nov. 19 podium presentation will cover clinical results with Symvess in military and civilian vascular trauma settings.
